Health Ministry Urgently Recalls Dangerous Drug - Details
According to the Health Ministry, Johnson & Johnson, the distributor of the drug IMAAVY in Israel, has decided to recall it from hospitals and medical clinics. The recall is coordinated with the Ministry of Health…
Assessment
The Health Ministry is pulling IMAAVY from Israeli hospitals and clinics after Johnson & Johnson, the distributor, flagged a manufacturing risk: glass particles in certain batches. This is a level-two recall, meaning the affected lots must be isolated and returned to SLA for a credit. The drug treats generalized myasthenia gravis in adults and teens 12 and older with specific antibodies. For patients on this therapy, the immediate concern is continuity of treatment, since a recall doesn't come with a substitute. Watch for which batch numbers are affected and how quickly the ministry or distributor offers an alternative supply.